• Careers
  • Contact Us
  • Emerson.com
  • English / United States [ Change ]
Shape Tomorrow's Manufacturing Facilities

Emerson Life Sciences Symposium

 

Join Your Peers in Philadelphia in March 2017

We started the Life Sciences Symposium in 2013 to drive innovation and meet the challenge of manufacturing more and better medicines at a lower cost. More than 100 participants from 22 companies joined us in 2013.

In the last three years, our user-driven group of industry experts has discussed challenges, explored opportunities, and worked steadfastly together to drive innovation. So far, we’ve seen two patents and progress toward a cost-effective measurement solution for single-use facilities. We’re just getting started.

 

LSSymposium_RegisterButton.jpg 
 
 
Keynote Speakers



Douglas B. Hausner, PhD
 
Rutgers University​​
​​​Doug Hausner is the Associate Director for Industrial Relations and Business Development with the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University in New Jersey, USA. C-SOPS focuses on the science based development of pharmaceutical products and processes. C-SOPS is the largest academic/industrial research consortium focused on pharmaceutical applications, involving over 100 academic researchers, and more than 50 industrial partners. C-SOPS has been directly involved in working with major pharmaceutical companies and the FDA on the first processes for continuous manufacturing of pharmaceutical solid dose products.​



Rob High
 
IBM Watson
​​​Rob High is the Vice President and Chief Technology Officer for IBM Watson, High leads the IBM team responsible for bringing cognitive computing to the world, supporting the development of deep natural language processing and other cognitive computing capabilities in the areas of speech, language, vision, and reasoning. Under his leadership, Watson is ushering in a new era in computing in which systems are able to interact in natural language, analyze large volumes of unstructured data, respond to complex questions with evidence-based answers, and discover new actionable patterns and insights. High is recognized as a global technical leader, and was named an IBM Fellow in 2008 for his pioneering work in the field of SOA and for his leadership on WebSphere.​

Session Topics
 
  
Managing Data through the Product Lifecycle
Managing data associated with a given product’s lifetime including recipes, formulas, materials, equipment, and licensing information is the crux of this topic. Pipeline acceleration is critically important for life sciences companies. Tools and methods that can aid to accelerate the transfer of new molecular entities from the laboratory to large-scale manufacturing are needed. Enterprise Recipe management, an end-to-end structured management of product recipes from early phases of development through commercial manufacturing is a key part of this topic.

  
Process Intelligence & Analytics
Drug makers are generating data from electronic systems at an accelerating rate. Data complexity already delays manufacturing and product decisions. Intelligence embedde​d in the data can be used to gain valuable insight to the manufacturing process. Visualizing this insight at the right time for decision making will provide significant impact on the process, release, and time to market. Deploying these capabilities throughout the industry’s manufacturing networks will require robust IT architectures and standard business practices, as well as careful consideration of several factors. Topics include real-time analytics, data integration from multiple sources, contextualization, and visualization to support timely process understanding and decision-making.

  
Flexible Facilities & Single-Use Technologies
Single-use technologies reduce drug manufacturers’ costs by increasing equipment utilization. But shifting from steel to plastic introduces significant challenges. These include managing the growing data flood and prudently embracing next-generation instrumentation, whose trustworthiness remains unproven. To adopt single-use technologies, manufacturers will need to anticipate how new automation and new production-scheduling and management approaches will affect data structures. This session discusses how to best support single-use technologies, including instrumentation and automation implementation strategies, as well as data integration.

  
Continuous Manufacturing
Many companies are keenly interested in the benefits of continuous manufacturing and have started investing in making this a reality for some of their products. The industry has initiated this in the oral solid dose side of the business, yet a few companies are looking at how to run biological processes in a more continuous manner. Process understanding, continuous control methodologies, materials management, and data management as well as international regulations are key components of this transition.



​​​ ​​​​​​​​
​​​​​​

 


March 28-30, 2017​ 
 Sofitel Philadelphia Hotel
 Philadelphia, Pennsylvania